Ben Casavant, PhD, CEO of Tasso, named EY Entrepreneur Of The Year 2026 Mountain West finalist after global growth
Ben Casavant, PhD, co-founder and CEO of Tasso, Inc., was named a finalist for EY US’s Entrepreneur Of The Year 2026 Mountain West award after leading Tasso’s global expansion and development of patient-centric blood collection technologies used in 60+ countries and all 50 U.S. states.
Tasso, Inc. Renews SOC 2 Type 2 Certification Following Independent Audit by Prescient Assurance
Tasso, Inc. announced it renewed its SOC 2 Type 2 certification after an independent audit by Prescient Assurance that produced an unqualified (clean) opinion, reaffirming the company’s commitment to protecting patient and client data across its API and online platforms.
Neurogen Biomarking partners with Tasso to use needle-free blood collection for home-based Alzheimer’s testing
Neurogen Biomarking will integrate Tasso’s virtually painless, needle-free blood collection devices into its home-based Alzheimer’s testing service, pairing blood-based biomarker tests with digital cognitive assessments, in-home collection, lab processing, and telehealth review by neurologists.
See all 10 news stories about Ben Casavant.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
Organizations
-
Tasso Co-Founder and Chief Executive Officer 2011–present · current
Education
-
University of Wisconsin-Madison PhD, Biomedical Engineering · 2009–2013
-
Wisconsin School of Business Minor, Entrepreneurship · 2009–2012
-
University of California, Berkeley BS, Bioengineering · 2005–2009